92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent ...

An update from Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( ($HK:2563) ) is now available. Beijing Biostar Pharmaceuticals has announced ...

Adolescents and young adults with stage IV cancer have unique primary tumor sources and survive longer with synchronous brain metastases than older adults.

In patients with metastatic breast cancer (BC), the prevalence of brain metastases increased with each treatment line, rising the most among patients with hormone receptor (HR)–negative, human ...

An announcement from Radiopharm Theranostics Limited ( ($AU:RAD) ) is now available. Radiopharm Theranostics announced that their Phase 2b trial ...

A recent Tampa, Fla.-based Moffitt Cancer Center study found that up to 25% of patients with stage 4 breast cancer may develop asymptomatic brain metastasis. The study, published Jan. 24 in ...

Cancer patients with brain metastases who develop venous thromboembolism can safely receive anticoagulant therapy without increasing their risk for intracranial hemorrhage, according to new data.

Real-time imaging has tracked what happens to cancer cells arriving in the brain, identifying a new strategy to prevent brain ...

Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 2563.HK), today announced that the first patient has been dosed for one of its key ...